Global Hospital Acquired Infection (HAI) Treatment market, valued at USD 18,340 million in 2024, is projected to reach USD 20,620 million by 2032, expanding at a CAGR of 1.7%. As part of a medica...
Global blood infection testing market is entering a period of accelerated transformation, driven by breakthroughs in diagnostics, rising sepsis incidence, and rapid adoption of molecular technolo...
Market Overview:
The infection control market is experiencing rapid growth, driven by rising incidence of healthcare-associated infections (hais), increasing focus on patient safety and stringen...
Global Infection Control and Biosafety Products market is entering a new era of accelerated expansion driven by heightened hygiene awareness, strengthened healthcare protocols, and technological ...
